Quantum-Si Incorporated (QSI) vs RxSight, Inc. (RXST)

Quantum-Si Incorporated and RxSight, Inc. are both Medical Devices companies. RxSight, Inc. is the larger, with a market value of $196.7M against $172.9M — 1.1× the size. RxSight, Inc. grew revenue faster over the last twelve months: −13.3% against −53.0%. RxSight, Inc. has the higher net margin (−36.8% vs −6,138.3%) and the higher return on invested capital (−63.2% vs −100.9%). Across the 16 metrics below, RxSight, Inc. leads on 13 and Quantum-Si Incorporated on 3.

Valuation

Metric QSI RXST Medical Devices median
P/E n/m n/m 22.18
P/S 112.63 1.52 2.70
P/B 1.00 0.73 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 0.24 11.78
EV/Sales 43.01 (0.11) 2.38
Earnings yield (55.42%) (24.25%) (8.22%)
Free cash flow yield (51.83%) (14.05%) (7.80%)

Profitability

Metric QSI RXST Medical Devices median
Gross margin 35.02% 77.50% 56.01%
Operating margin (6,887.79%) (43.20%) (15.03%)
Net margin (6,138.26%) (36.80%) (20.40%)
Free cash flow margin (5,837.26%) (21.29%) (7.24%)
Return on equity (49.11%) (17.35%) (15.32%)
Return on assets (43.98%) (14.19%) (19.72%)
Return on invested capital (100.92%) (63.16%) (10.33%)

Growth

Metric QSI RXST Medical Devices median
Revenue growth (TTM) (52.96%) (13.25%) 8.80%
EPS growth (last fiscal year) 28.17% (33.80%) —
Revenue growth, 5-year CAGR — 55.74% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QSI RXST Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 9.97 4.07 2.50
Net debt to EBITDA 1.36 4.27 0.49

Dividend

Metric QSI RXST Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric QSI RXST Medical Devices median
Market cap 172.91m 196.74m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack